Skip to main content
. Author manuscript; available in PMC: 2024 Jul 25.
Published in final edited form as: Am J Geriatr Psychiatry. 2023 Sep 3;32(1):98–113. doi: 10.1016/j.jagp.2023.08.017

TABLE 1.

Factors Suggestive of TDP-43 Proteinopathies in Patients With Late-onset NPS and Clinical Action Points

Red Flags for Possible TDP-43 Proteinopathy Clinical Action Points
Late-onset hallucinations and/or delusions Explore other indicators, cognitive testing, neuroimaging
Nonpsychotic late-onset NPS Explore other indicators – investigate only if other factors present
Family history of FTD, ALS, or early-onset dementia Collateral history from family +/− genetic testing and referral to genetic counselor if positive cases
bvFTD features, including hyperorality and stereotypies Referral to specialty clinics, neuroimaging, neuropsychology, social cognition tests
Language disturbances Neuropsychological +/− speech therapy assessment, neuroimaging
Cognitive deficits Neuropsychological testing
Motor weakness Neurological exam +/− EMG

Notes: ALS: amyotrophic lateral sclerosis; bvFTD: behavioral variant frontotemporal dementia; EMG: electromyography; FTD: frontotemporal dementia; NPS: neuropsychiatrie symptoms; TDP-43: transactive response DNA-binding protein 43.